Back to catalogue
№ 272 42 filings · 2021-08-25 → 2026-08-27

OAKLEY CAPITAL INVESTMENTS LIMITED

OCI
Financial Services Share price 542p Market cap £890m Overall fit 430 /1000

Fairly priced LPE trust trading at 33% discount to NAV with a diversified 40+ company European PE portfolio. Genuine but modest AI-adjacent exposure (TechInsights, Bridewell/I-TRACING, vLex/Clio) and low operating leverage at the vehicle level cap the fit with the strategy's AI-receiver + long-tail-upside brief; downside protection is decent but the upside is capped by the mechanics of a listed PE trust.

Fair value range 547p–625p Mid case · £963m
Absolute upside +8.2% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • Quarterly NAV disclosure with contributor attribution
  • 10-year NAV CAGR ~15% validated by multiple exits above carrying value
  • Discount-to-NAV methodology is standard for LPE
Limits the call
  • NAV depends on unobservable marks in unlisted PE holdings
  • Sector discount is structurally sticky and may not narrow
Methodology

Discount-to-NAV vs LPE peer set

In one line · bull case

Diversified pan-European PE portfolio with a 15% 10-year NAV CAGR available at ~33% discount to NAV, with modest AI-adjacent kickers.

In one line · biggest risk

The listed PE discount is chronic and NAV marks on unlisted holdings could reset lower if private multiples re-rate.

Drivers
AI beneficiary 38 /100
Indirect exposure via TechInsights (semi intelligence), Bridewell/I-TRACING (cyber) and vLex/Clio (legaltech), but ~2/3 of NAV is physical-delivery businesses.
Operating leverage 30 /100
Vehicle-level costs are fixed but small; look-through portfolio is mixed and doesn't offer a clear high-leverage inflection.
Earnings vs expectations 55 /100
NAV updates broadly in line to modestly ahead; realised exits (vLex, TechInsights, IU) at premiums to prior carrying values.
Growth momentum 55 /100
Underlying portfolio EBITDA growth 11–15% p.a.; NAV growth mid-single-digit at the vehicle level; H1 2026 NAV +6%.
Moat 50 /100
Manager reputation and founder network are real advantages but investor holds the fund vehicle, not the operating businesses.
Earnings quality 55 /100
NAV growth mainly organic EBITDA, with modest FX and multiple movement; unlisted marks introduce inherent judgement.
Management quality 65 /100
Oakley Capital advisor has a strong 20+ year track record; board improvements (Main Market move, buyback policy) are shareholder-friendly.
Cyclicality 55 /100
Diversified across four sectors; PE valuations and exit timing are cyclical, offset by non-discretionary education/TIC exposure.
Leverage 35 /100
Vehicle net cash-ish (~£155m liquidity vs £940m commitments); underlying portfolio net debt/EBITDA 4.1x is moderate for PE.
Value-trap signals · 5
  • Persistent 30%+ discount to NAV widening despite NAV growth
  • Uncalled commitments (~£640m to be drawn) materially exceed liquidity (£155m)
  • Related-party governance friction (43% against re-election of Founder Director in 2026)
  • Legacy direct investments (Time Out required distressed placing; North Sails still on balance sheet)
  • Portfolio EV/EBITDA of 16.3x not conservative in a bearish multiple-reset scenario

OAKLEY CAPITAL INVESTMENTS LIMITED (OCI) — Research note

Executive summary

OCI is a Bermuda-domiciled, LSE Main Market-listed closed-end investment company that provides listed access to Oakley Capital's pan-European lower/mid-market private equity funds (40+ portfolio companies across Technology, Education, Consumer and Business Services). The trajectory over the past five years has been steady NAV compounding (10-yr NAV CAGR of ~15%, 2026-07-30 trading update) driven mostly by portfolio EBITDA growth (11–15% p.a.) with valuation multiples broadly flat, while the shares have de-rated to a persistent ~30%+ discount to NAV. The single most important point for valuation today is that the shares trade at ~33% below the disclosed 30-Jun-2026 NAV per share of 782p, roughly in line with the LPE sector discount rather than materially cheaper.

Fair value estimate

  • Methodology: NAV-based (discount-to-NAV) for a listed PE fund-of-funds — the appropriate approach given the vehicle is a look-through claim on Oakley fund NAVs.
  • Inputs: H1 2026 NAV/share = 782p 2026-07-30. Portfolio-level EV/EBITDA = 16.3x, Net Debt/EBITDA = 4.1x, average EBITDA growth 11% 2026-03-12 Final Results. Peer LPE discount ~26–32% 2026-04-29 Q1 trading update.
  • Fair value range: apply a 20–30% discount to NAV: 625p (high) – 547p (low), midpoint ~586p. This assumes discount tightens modestly from 33% back toward the sector 12-mo average.
  • Implied market cap range: £899m – £1,027m (mid ~£963m).
  • vs current market cap of £851.1m: absolute upside to midpoint ≈ +11–12%, upside to top of range ≈ +19%.
  • View: fair-to-modestly-undervalued.

Sector context

  • Sector classification confirmed: Financial Services (Listed Private Equity sub-sector).
  • Quality/growth/leverage profile is broadly in line with LPE peers — solid PE track record (10-yr NAV CAGR 15%), portfolio leverage of 4.1x (moderate for PE), balance sheet at the vehicle level uses moderate gearing.
  • Peers: HgCapital Trust (HGT), ICG Enterprise Trust (ICGT), HarbourVest Global (HVPE), Pantheon International (PIN) [named directly at src: 2026-04-29].

Investment thesis

  1. Persistent 33% discount to a demonstrably compounding NAV — 10-year NAV CAGR of 15% and shareholder return CAGR of 16% 2026-07-30 trading update. Even if the discount only normalises to the sector average of 26–28%, the shares offer mid-teens uplift before any NAV growth.
  2. AI-adjacent portfolio exposure via TechInsights, Bridewell/I-TRACING and vLex/Clio — TechInsights (chip intelligence platform) was called out as a top NAV contributor "as the AI boom drove demand for its services" 2026-03-12 Final Results. Bridewell + I-TRACING combined form an independent European cyber services leader 2025-09-11 Interim Results. Not a pure-play AI receiver, but real, ring-fenced AI upside within a diversified portfolio.
  3. Improved shareholder-return framework and NAV floor — dividend cancelled and replaced with a minimum £20m annual buyback (£50m in 2025) at material discounts, adding ~11p to NAV per share over the 2025 programme 2026-01-28. Main Market/FTSE 250 listing (2025) improves institutional access 2025-09-11.

Key risks

  1. Structural LPE discount may not close — sector average discount is 26–28% and has been sticky; even quality PE trusts trade below NAV for long periods 2026-04-29 Q1 update, sector reference.
  2. Uncalled commitment overhang — outstanding commitments of £940m as at 30-Jun-2026 (of which ~£640m expected to be called over 5 years) against liquidity of £155m 2026-07-30. Manageable but constrains flexibility if exits stall.
  3. Portfolio company valuation transparency and AI substitution risk — average portfolio multiple 16.3x EV/EBITDA is not cheap; specific stress spots (Time Out down 32p in 2025, Steer/ACE Education/Contabo weaker in 2025) show valuation risk in a bearish scenario 2026-03-12 Final Results, 2026-01-28 trading update.

Operating leverage

Operating leverage at the OCI vehicle level is low: the listed company is essentially a look-through claim on Oakley fund NAVs, with a fixed management fee to the Investment Adviser. Incremental "revenue" (NAV growth) doesn't scale disproportionately vs cost. Look-through into portfolio companies, operating leverage is uneven: ~16% of NAV in vertical mission-critical software (higher leverage) 2026-03-12, with the rest across TIC services (Phenna), education (IU-successor, K12 platforms), luxury consumer brands, and a broad mix of asset-light service businesses. Sustained ~11–15% organic EBITDA growth 2026-03-12 demonstrates real underlying earnings leverage, but not the "10-20% revenue beat → doubling of profit" outcome the investor is targeting. There is no obvious single fixed-cost inflection point.

Value-trap signals

  • LPE-sector discount has widened, not narrowed, despite consistent NAV growth (share price down 16% H1-2026 vs NAV up 6%) 2026-07-30.
  • Time Out (2% of NAV) required a distressed equity placing at 30% discount to market; OCI participated with £3m and loan-note extension 2025-12-18.
  • Related-party governance friction — Peter Dubens (Founder Director) re-elected with 43% against in 2026 AGM 2026-06-01.
  • Commitment stack exceeds liquidity by a material margin.
  • Direct legacy positions (Time Out, North Sails) still on balance sheet.

Earnings vs. expectations

As an investment trust, OCI's "results" are NAV updates, not P&L beats/misses in the traditional sense. Across the filings, NAV per share updates have generally landed close to prior quarterly guidance, driven predominantly by portfolio EBITDA growth (14% in 2023, 15% in 2024, 11% in 2025 average LTM EBITDA growth). Announced transactions (vLex exit >6x return, TechInsights sale ~19x/82% IRR, IU Group refinancings) have been executed at premiums to prior carrying values 2025-09-11, 2022-03-10, 2026-03-12, suggesting valuations have been conservative rather than aggressive. Pattern: in-line to modestly-ahead at NAV level; share-price performance has consistently lagged NAV, reflecting sector-wide discount widening rather than delivery misses.

Conviction

3 — moderate. Anchors: (i) NAV is disclosed quarterly with detailed contributor attribution; (ii) 10-year track record of ~15% NAV compounding with realised exits validating carrying values (e.g. vLex >6x, IU Group ~£240m realisation, TechInsights ~19x); (iii) methodology (discount-to-NAV) is standard for LPE. Caveats: (i) NAV depends on unobservable multiple/EBITDA marks in unlisted holdings — genuine downside risk if PE multiples reset; (ii) the LPE discount is chronic and my central case relies on partial re-rating that may not materialise.

Driver scoring (0-100) — see JSON below.

Overall score: 430. Fair-priced, diversified LPE vehicle with genuine but modest AI-adjacent exposure (TechInsights, cyber, legaltech), limited operating leverage at the vehicle level, adequate downside protection via portfolio diversification and 15%-CAGR track record, but the AI-receiver thesis is dilute and the discount-close is not a "long-tail" outcome — capped upside profile. Fits the "worth knowing about" band rather than a strategy core holding.

Filings consulted · 49

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-08-27Notice OF Results And Investor Presentation2026-08-27_9742174_notice-of-results-and-investor-presentation.md0.70
  2. 2026-07-30Trading Update For The 6 Months Ended 30 June 262026-07-30_9694665_trading-update-for-the-6-months-ended-30-june-26.md0.85
  3. 2026-06-01Result OF Agm2026-06-01_9595739_result-of-agm.md0.30
  4. 2026-05-06Notice OF Agm2026-05-06_9553656_notice-of-agm.md0.30
  5. 2026-04-29Trading Update For The 3 Months Ended 31 March 262026-04-29_9542876_trading-update-for-the-3-months-ended-31-march-26.md0.85
  6. 2026-03-12Final Results For The Year Ended 31 December 20252026-03-12_9470269_final-results-for-the-year-ended-31-december-2025.md1.00
  7. 2026-03-04Notice OF Results And Investor Presentation2026-03-04_9457115_notice-of-results-and-investor-presentation.md0.70
  8. 2026-01-28Trading Update For The Year Ended 31 December 20252026-01-28_9390321_trading-update-for-the-year-ended-31-december-2025.md0.72
  9. 2025-12-18Oci TO Participate IN Time Out Equity Placing2025-12-18_9305267_oci-to-participate-in-time-out-equity-placing.md0.59
  10. 2025-10-29Q3 Trading Update And Board Appointments2025-10-29_9200444_q3-trading-update-and-board-appointments.md0.72
  11. 2025-09-11Interim Results For The 6 Months Ended 30 June 252025-09-11_9100519_interim-results-for-the-6-months-ended-30-june-25.md0.77
  12. 2025-09-10Result OF Agm Replacement2025-09-10_9097742_result-of-agm-replacement.md0.26
  13. 2025-09-02Result OF Agm2025-09-02_9085157_result-of-agm.md0.26
  14. 2025-08-28Notice OF Results And Investor Presentation2025-08-28_9076559_notice-of-results-and-investor-presentation.md0.46
  15. 2025-07-30Trading Update For The 6 Months Ended 30 June 20252025-07-30_9011339_trading-update-for-the-6-months-ended-30-june-2025.md0.55
  16. 2025-04-30Trading Update For The 3 Months Ended 31 March 252025-04-30_8852992_trading-update-for-the-3-months-ended-31-march-25.md0.55
  17. 2025-03-13Final Results For The Year Ended 31 December 20242025-03-13_8776766_final-results-for-the-year-ended-31-december-2024.md0.65
  18. 2025-02-26Notice OF Results And Investor Presentation2025-02-26_8752572_notice-of-results-and-investor-presentation.md0.46
  19. 2025-01-29Trading Update For The Year Ended 31 December 20242025-01-29_8710448_trading-update-for-the-year-ended-31-december-2024.md0.55
  20. 2024-10-23Trading Update For The 3 Months Ended 30 Sep 20242024-10-23_8502585_trading-update-for-the-3-months-ended-30-sep-2024.md0.55
  21. 2024-09-12Interim Results For The 6 Months Ended 30 June 242024-09-12_8412396_interim-results-for-the-6-months-ended-30-june-24.md0.58
  22. 2024-08-29Notice OF Results And Investor Presentation2024-08-29_8389030_notice-of-results-and-investor-presentation.md0.46
  23. 2024-07-24Trading Update For The 6 Months Ended 30 June 20242024-07-24_8327055_trading-update-for-the-6-months-ended-30-june-2024.md0.38
  24. 2024-06-03Result OF Agm2024-06-03_8239553_result-of-agm.md0.14
  25. 2024-04-24Trading Update For The 3 Months Ended 31 March 242024-04-24_8153215_trading-update-for-the-3-months-ended-31-march-24.md0.38
  26. 2024-03-14Dividend Declaration2024-03-14_8089001_dividend-declaration.md0.14
  27. 2024-03-14Annual Results 20232024-03-14_8086825_annual-results-2023.md0.45
  28. 2024-03-04Notice OF Results And Investor Presentation2024-03-04_8067555_notice-of-results-and-investor-presentation.md0.32
  29. 2024-01-24Trading Statement2024-01-24_8003245_trading-statement.md0.38
  30. 2023-11-28Result OF Agm2023-11-28_7908097_result-of-agm.md0.14
  31. 2023-10-30Notice OF Agm And Directorate Change2023-10-30_7846319_notice-of-agm-and-directorate-change.md0.14
  32. 2023-10-25Trading Update For The 3 Months Ended 30 Sep 20232023-10-25_7837140_trading-update-for-the-3-months-ended-30-sep-2023.md0.38
  33. 2023-09-14Interim Results For The 6 Months Ended 30 June 232023-09-14_7754341_interim-results-for-the-6-months-ended-30-june-23.md0.41
  34. 2023-09-14Interim Results 2023 Replacement2023-09-14_7756560_interim-results-2023-replacement.md0.41
  35. 2023-08-30Notice OF Results And Investor Presentation2023-08-30_7723896_notice-of-results-and-investor-presentation.md0.32
  36. 2023-07-26Trading Update For The 6 Months Ended 30 June 20232023-07-26_7654897_trading-update-for-the-6-months-ended-30-june-2023.md0.21
  37. 2023-04-26Trading Update For The 3 Months Ended 31 Mar 20232023-04-26_4404_trading-update-for-the-3-months-ended-31-mar-2023.md0.21
  38. 2023-03-09Final Results For The Year Ended 31 December 20222023-03-09_7389096_final-results-for-the-year-ended-31-december-2022.md0.25
  39. 2023-02-27Notice OF Results And Investor Presentation2023-02-27_7235793_notice-of-results-and-investor-presentation.md0.17
  40. 2023-01-25Trading Update For The Year Ended 31 December 20222023-01-25_7227293_trading-update-for-the-year-ended-31-december-2022.md0.21
  41. 2022-10-26Trading Update For The 3 Months Ended 30 Sep 20222022-10-26_7158653_trading-update-for-the-3-months-ended-30-sep-2022.md0.21
  42. 2022-09-30Result OF Agm2022-09-30_7173008_result-of-agm.md0.07
  43. 2022-09-08Interim Results For The 6 Months Ended 30 June 222022-09-08_7269516_interim-results-for-the-6-months-ended-30-june-22.md0.23
  44. 2022-08-26Notice OF Results And Investor Presentation2022-08-26_7102608_notice-of-results-and-investor-presentation.md0.17
  45. 2022-07-27Trading Update For The 3 Months Ended 30 June 20222022-07-27_7179690_trading-update-for-the-3-months-ended-30-june-2022.md0.21
  46. 2022-04-27Trading Update For The 3 Months Ended 31 March 222022-04-27_7085475_trading-update-for-the-3-months-ended-31-march-22.md0.21
  47. 2022-03-10Final Results For The Year Ended 31 December 20212022-03-10_6845070_final-results-for-the-year-ended-31-december-2021.md0.25
  48. 2022-01-26Trading Update For The Year Ended 31 December 20212022-01-26_6953004_trading-update-for-the-year-ended-31-december-2021.md0.21
  49. 2021-08-25Notice OF Interim Results And Webcast Presentation2021-08-25_6635458_notice-of-interim-results-and-webcast-presentation.md0.09

This research note was authored by a large language model after reading 42 regulatory filings published between 2021-08-25 and 2026-08-27. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.